Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;78(12):5139-5161.
doi: 10.1007/s00018-021-03842-6. Epub 2021 May 8.

Nanoparticle-based approaches to target the lymphatic system for antitumor treatment

Affiliations
Review

Nanoparticle-based approaches to target the lymphatic system for antitumor treatment

Xingzhou Peng et al. Cell Mol Life Sci. 2021 Jun.

Abstract

Immunotherapies have been established as safe and efficient modalities for numerous tumor treatments. The lymphatic system, which is an important system, can modulate the immune system via a complex network, which includes lymph nodes, vessels, and lymphocytes. With the deepening understanding of tumor immunology, a plethora of immunotherapies, which include vaccines, photothermal therapy, and photodynamic therapy, have been established for antitumor treatments. However, the deleterious off-target effects and nonspecific targeting of therapeutic agents result in low efficacy of immunotherapy. Fortunately, nanoparticle-based approaches for targeting the lymphatic system afford a unique opportunity to manufacture drugs that can simultaneously tackle both aspects, thereby improving tumor treatments. Over the past decades, great strides have been made in the development of DC vaccines and nanomedicine as antitumor treatments in the field of lymphatic therapeutics and diagnosis. In this review, we summarize the current strategies through which nanoparticle technology has been designed to target the lymphatic system and describe applications of lymphatic imaging for the diagnosis and image-guided surgery of tumor metastasis. Moreover, improvements in the tumor specificity of nanovaccines and medicines, which have been realized through targeting or stimulating the lymphatic system, can provide amplified antitumor immune responses and reduce side effects, thereby promoting the paradigm of antitumor treatment into the clinic to benefit patients.

Keywords: Combinational immunotherapy; DC vaccine; Image-guided therapy; Lymphatic targeting; Lymphoscintigraphy; Nanoplatform; Tumor metastasis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Preclinical applications of lymphatic imaging: a system mapping of the lymphatic system [90]. Copyright 2019, American Chemical Society. b In vivo tracking of DC vaccines with multimodality imaging [107]. c Image-guided photothermal therapy [113]. Copyright 2018, Elsevier Ltd. d Image-guided surgery [24]. Copyright 2017, American Chemical Society
Fig. 2
Fig. 2
Schematic illustration of the cancer-immunity cycle

Similar articles

Cited by

References

    1. Klevorn LE, Teague RM. Adapting cancer immunotherapy models for the real world. Trends Immunol. 2016;37(6):354–363. doi: 10.1016/j.it.2016.03.010. - DOI - PMC - PubMed
    1. Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20. doi: 10.1038/nrc.2016.108. - DOI - PMC - PubMed
    1. Buchbinder EI, Hodi FS. Immune-checkpoint blockade—durable cancer control. Nat Rev Clin Oncol. 2016;13(2):77–78. doi: 10.1038/nrclinonc.2015.237. - DOI - PubMed
    1. Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O’Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–291. doi: 10.1038/nature19057. - DOI - PMC - PubMed
    1. Ribas A. Adaptive immune resistance: how cancer protects from immune attack. Cancer Discov. 2015;5(9):915. doi: 10.1158/2159-8290.CD-15-0563. - DOI - PMC - PubMed

Substances